Last updated on July 2018

Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy


Brief description of study

Study E7389-M044-504 is an observational, post-authorization, single-arm, prospective, multicenter cohort study conducted to characterize and determine the incidence of eribulin-induced peripheral neuropathy (PN), and the frequency and time to resolution of eribulin-induced PN in participants treated with eribulin in a real-life setting for locally advanced or metastatic breast cancer following one or two prior chemotherapeutic regimens for advanced disease.

Clinical Study Identifier: NCT03027245

Contact Investigators or Research Sites near you

Start Over

Helga Schmitz

Eisai Trial Site 1
Lahr, Germany
  Connect »

Helga Schmitz

Eisai Trial Site 1
Offenburg, Germany
9.84miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.